Environmental, Social And Governance (ESG) Statement

Overview

The report describes Mesoblast's sustainability purpose as seeking to provide access to treatment for patients with unmet medical needs, supported by corporate values and ESG governance. It reports Board oversight of ESG-related risks and opportunities through regular Board meetings and committees. FY22 workforce disclosures report 33% female senior executives and 52% female total workforce, while one female was appointed to two Board vacancies. Environmental initiatives included green electricity sourcing and office waste recycling, and expanded access programs provided remestemcel-L to more than 250 children at no cost plus three children under a COVID-19 protocol.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2022
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services